CoTherix Ventavis Clears FDA For Pulmonary Arterial Hypertension

Launch is planned for the second quarter following export clearance from regulators in Spain, where iloprost is manufactured. The timing will also allow CoTherix to hire and train the Ventavis sales force prior to making product available.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet